stockrow
Friday 6 November 2026
Export GRAL’s income statement to Excel — free account
GRAIL, Inc.
GRAL Healthcare Diagnostics & Research
GRAIL, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $147.2 million, up 17.2% from fiscal 2024.
- Revenue
- +3.71%
- EPS
- +10.2%
- Free cash flow
- −24.9%
Quarter to September 2026, against a year earlier
121.18
2.05
+1.72%
Follow GRAL
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
— | — | 6 | — |
| (16.07%) | (16.09%) | (16.12%) | (17.31%) | ||
| (13.83%) | (13.99%) | (14.12%) | (15.24%) | ||
ROIC |
(21.00%) | (20.28%) | (20.79%) | (14.74%) | |
Return on Tangible Assets |
(44.10%) | (46.48%) | (44.73%) | (51.34%) | |
Average Days of Receivables |
45.37 | 47.57 | 43.64 | 41.62 | |
Free Cash Flow per Share |
(8.16) | (7.19) | (6.87) | (6.67) | |
Free Cash Flow |
(299.92) | (292.33) | (296.16) | (312.00) | |
Capital Expenditures |
(0.91) | (1.35) | (1.41) | (5.76) | |
| Other line items | |||||
Cash ROIC |
(8.61%) | (8.80%) | (8.70%) | (12.72%) | |
Accounts Receivable Turnover |
7.62 | 7.87 | 9.16 | 9.44 | |
Accounts Payable Turnover |
60.56 | 40.83 | 32.09 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | — | |
Average Days of Payables |
3.62 | 8.00 | 12.18 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | — | |
Tax Rate |
(0.24) | (0.23) | (0.26) | (0.26) | |
Research and Development Expense of Revenue |
133.04% | 121.82% | 115.57% | 111.89% | |
Selling, General and Administrative Expense of Revenue |
187.40% | 172.42% | 176.14% | 186.44% | |
Share Based Compensation of Revenue |
39.60% | 37.70% | 38.88% | 38.55% | |
Operating CF/Net income |
0.73 | 0.74 | 0.75 | 0.75 | |
Depreciation/Fixed assets |
3.15 | 3.39 | 3.58 | 0.00 | |
Capex/Depreciation |
(0.01) | (0.01) | (0.01) | 0.00 | |
Revenue per Share |
4.00 | 3.84 | 3.83 | 3.56 | |
Operating CF per Share |
(8.14) | (7.16) | (6.84) | (6.55) | |
Capex per Share |
(0.02) | (0.03) | (0.03) | (0.12) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.03 |
Columns are period end dates · fundamentals updated 5 Nov 2026